- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05511714
Expanded Access [11C] Methionine PET Imaging
The participants are being asked to get this PET scan because the participants have or may have cancer in the central nervous system (head, neck, or spine), and the investigator and the patient's physician thinks that this scan may provide useful information for the participant's treatment.
Primary Objective
To provide expanded access to L-[11C]methionine as a positron-emitting tracer in children and young adults for the positron emission tomography (PET) imaging of neoplasms of the central nervous system (CNS) and head and neck to guide therapeutic management of disease.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Expanded Access Type
- Individual Patients
Contacts and Locations
Study Locations
-
-
Tennessee
-
Memphis, Tennessee, United States, 38105
- Available
- St. Jude Children's Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All participants under the care of a SJCRH physician with known or suspected neoplastic disease of the CNS or head and neck are eligible for participation.
- No limit on age.
- Patients of all genders and all ethnic groups under the care of a SJCRH physician.
- Female participants of child-bearing age must not be lactating due to theoretical potential harm to the infant from exposure to radiation.
- Informed consent signed by participant, parent, or guardian according to the guidelines of the Institutional Review Board.
Exclusion Criteria:
- More than six L-[11C]methionine PET scans within the previous 12 months.
- Inability or willingness of patient, parent, or guardian to consent.
Study Plan
How is the study designed?
Collaborators and Investigators
Investigators
- Principal Investigator: Barry L. Shulkin, MD, MBA, St. Jude Children's Research Hospital
Publications and helpful links
Study record dates
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EXAMPT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Neoplasms
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
IRCCS Policlinico S. MatteoNestlé Health Science Spain; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
IntraGel TherapeuticsNot yet recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHead and Neck CarcinomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Completed
-
Jonsson Comprehensive Cancer CenterWithdrawnHead and Neck CarcinomaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)WithdrawnHead and Neck CarcinomaUnited States
Clinical Trials on L-(11C) methionine
-
St. Jude Children's Research HospitalRecruitingHodgkin Lymphoma | Osteosarcoma | Ewing Sarcoma | Ependymoma | Medulloblastoma | Non Hodgkin Lymphoma | Neuroblastoma | Craniopharyngioma | Rhabdomyosarcoma | Other | Brain Stem Glioma | Brain Tumors and/or Solid Tumors Including | High Grade CNS Tumors | Low Grade CNS TumorsUnited States
-
Masaryk Memorial Cancer InstituteActive, not recruiting11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET) (GlioMET)Glioblastoma MultiformeCzechia
-
Hospices Civils de LyonCompleted
-
Hospices Civils de LyonRecruiting
-
University of British ColumbiaBritish Columbia Cancer AgencyUnknownPrimary HyperparathyroidismCanada
-
Pomeranian Medical University SzczecinLaval UniversityCompletedPrimary Biliary CirrhosisPoland
-
Deakin UniversityCompleted
-
Mclean HospitalStanley Medical Research InstituteCompletedDepression | Bipolar Disorder | Bipolar DepressionUnited States
-
IRCCS San RaffaeleRecruiting
-
Mayo ClinicCompleted